Reach Us +447480022765
Thoracic Determination Behandccedil;et's Disease | OMICS International | Abstract
ISSN: 2161-105X

Journal of Pulmonary & Respiratory Medicine
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article

Thoracic Determination Behçet's Disease

Bopaka RG*, Khattabi WE, Souki N, Sellal H, Bied BE, Afif H and Aichane A

Department of Respiratory Diseases, Hospital on August 20, CHU Ibn Rochd , Casablanca, France

*Corresponding Author:
Bopaka RG
Department of Respiratory Diseases
Hospital on August 20 , CHU Ibn Rochd
Casablanca, France
Tel: 00212-652-23-59-86
Email: [email protected]

Received date: June 14, 2014; Accepted date: July 21, 2014; Published date: July 23, 2014

Citation: Bopaka RG, Khattabi WE, Souki N, Sellal H, Bied BE, et al. (2014) Thoracic Determination Behçet's Disease. J Pulm Respir Med 4:197. doi:10.4172/2161-105X.1000197

Copyright: © 2014 Bopaka RG, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Behçet's disease is a multisystem vasculitis of unknown etiology. Thoracic lesions are dominated by venous and arterial diseases. We identified 21 cases with a hospital prevalence of Behçet's disease between January 1997 and June 2012. The prevalence was of 0.2%. Hemoptysis was the most common symptom and superior vena cava syndrome was the most common sign. Chest Computerized Tomography (CT) scan had confirmed thrombosis of the superior vena cava in 15 patients, and the pulmonary artery aneurysms in 6 patients, three of them were complicated by thrombosis. Patients followed for thrombosis of the superior vena cava received anticoagulant therapy, corticosteroid and immunosuppressive. The combination of corticosteroids, colchicine and immunosuppressive drugs was prescribed in patients with pulmonary aneurysms before surgical treatment. The authors concluded through this study for the rarity and severity of thoracic manifestations of Behçet's disease. Therapeutic means are limited and the prognosis is poor. Thoracic lesions of Behçet's disease are not rare in Mediterranean countries, diagnosis is easy with CT scan, but there’s a late in treatment. In these cases, prognosis is conditioned by thoracic lesions.